Specialised Dietary Fibre Intervention in Children with Type 1 Diabetes - is it safe, feasible and tolerable?

Queensland Children's Hospital0 个研究点目标入组 30 人开始时间: 2021年11月10日最近更新: 2022年11月14日

适应症

试验速览

暂无简介。

•Children and adolescents aged 5 – 14 years (inclusive) with T1D that was diagnosed at least 3 months prior to entry into the study
•- HbA1c less than or equal to 9% (75 mmol/mol) at the time of entry into the study
•- BMI between 15th centile and 85th centile, inclusive
•- The child/adolescent and their family are willing and able to follow the study protocol

•- Concomitant disease or treatment that may, in the judgement of the investigators, impact on glycaemic control, insulin requirements or other outcome measures
•- Hypoglycaemia unawareness
•- History or symptoms of malabsorption or gastrointestinal disease, including coeliac disease
•- Known liver or renal disease
•- On a restricted or special diet that would impact their ability to take the supplement e.g. intermittent fasting or ketogenic diet
•- Use of medication other than insulin that affects glucose homeostasis
•- Antibiotic usage within the six weeks prior to entry into the study or anticipated usage during the study

发起方

Queensland Children's Hospital